NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
24/03/2026
Voltar para busca
Dado oficial do USPTO
FORTREA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
FORTREA
ST13
US500000097779230Classe
35, 42, 44
Pedido
97779230
Registro
8188092
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
25/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 42, 44
Data de depósito
03/02/2023
Data de registro
24/03/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/03/2026
Última transação
25/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Primeiro uso
09/02/2023
Primeiro uso no comércio
2023-05-00
Código do desenho
4
Tipo de titular
03
Localização do titular
DURHAM, NC, US
Examinador
DIGAN, MATTHEW M
Unidade examinadora
N60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
FORTREA INC.
Labcorp Drug Development Inc.
Representantes
Laura C. Miller KILPATRICK TOWNSEND & STOCKTON LLP
Classificação técnica
Classes Nice
Classe 35Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business consultingmanagementplanning services in the field of clinical trials; regulatory submission managementassisting others in preparing and filing applications with governmental regulatory bodies for approval and post-approval actions related to drugs and medical devices; economic forecasting and analysis in the field of pharmaceuticalbiotechnologymedical device industries; business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; business management servicessupply and demand forecasting in connection with drug supplies for clinical trials; recruitment advertisement servicesposting of clinical trial notices for the purpose of recruiting patients and volunteers for participation in clinical trials for the testing of drugs; business administration of patient reimbursement programs; business advisory servicesbusiness consultancy servicesbusiness data analysisbusiness information servicesbusiness management consultingbusiness strategy development servicesmarket intelligence servicesmarket researchmarketing serviceselectronic data collection and data submission services for business purposesdatabase managementbusiness project management services all in the fields of clinical trials and post approval pharmaceuticalsmedical devicesbiotechnology; market research and business marketing consulting services in the fields of international health and pharmaceuticalbiotechnologymedical device industries; market analysis in the field of international health and in the pharmaceuticalbiotechnologymedical device industries; providing business and statistical information for business purposes and data processing servicesall in the field of international health and in the pharmaceuticalbiotechnologymedical device industries
Classe 42
Pharmaceutical drug development services; design and testing of new productsmedical devicesfor others; research and development in the fields of pharmaceuticalsmedical devicesbiotechnology; medical and scientific research in the field of clinical trialsdesigningorganizingconductingmonitoringmanaging clinical trials and studies on pharmaceuticals and medical devices for others; scientific consulting services for others in the field of designplanningimplementation project management of clinical trials and studies on pharmaceuticals and medical devices; providing temporary use of online non-downloadable software for the collectioncalibrationanalysis and reporting of medical and scientific research data in connection with clinical trials and studies on pharmaceuticals and medical devices; scientific laboratory services; scientific laboratory servicesformulating and bioprocessing pharmaceuticals; rental of laboratory apparatus and instruments; database design and development in the field of pharmaceutical drug development and medical device testing services; design and development of software for use in conducting research in pharmaceutical and medical device development studies; providing online computer databases in the fields of research and development of pharmaceuticalsmedical devicesbiotechnology; data mining in the fields of research and development of pharmaceuticalsmedical devicesbiotechnology; providing a website featuring technology enabling users to remotely trackmonitoranalyzegenerate reports with information and statistics from clinical trials and studies on pharmaceuticals and medical devices; advisory services for others in the field of pharmaceutical drug development; providing medical and scientific research information in the fields of biochemistrypharmaceuticals and clinical trials; providing online non-downloadable software for trackingmonitoringanalyzinggenerating and reporting information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devices; application service provider (ASP) featuring software for use in database and record management in the fields of clinical trials and post-approval research for pharmaceuticals and medical devices; providing temporary use of online non downloadable software for collectingorganizingreporting clinical trial information and trial results; providing temporary use of online non-downloadable software for uploading and accessing test results in the field of medical testing for scientific research purposes; providing temporary use of online non-downloadable software for storingretrievingaccessingdisplayingmanaginganalyzingreviewing information and data in the fields of pharmaceuticalsmedical devicesbiotechnology; scientific study and research in the field of production of pharmaceuticals and medical devices; providing online non-downloadable software for planningmanaging and supporting clinical trials; medical and scientific clinical research for others in the field of the production of pharmaceuticalsbiopharmaceuticalsmedical devices; software as a service (SAAS) serviceshosting software for use by others for the collectionreviewanalysisreporting of clinical trial and drug development information; research and development in the field of pharmaceuticalsbiopharmaceuticalsmedical devicesmedical diagnostics; clinical research in the field of production of pharmaceuticalsmedical devices and medical diagnostics; providing interactive web sites featuring technology that enables users to collectreviewanalyze and report on clinical research and drug development information; providing temporary use of online non downloadable software to allow users to collectreviewanalyze and report on clinical research and drug development
Classe 44
Medical services in the field of pharmacology and specimen collection and procedures in connection with clinical trials; providing an online computer database featuring medical information in the field of patient management and outcomes; providing a website featuring medical information in the fields of clinical trials and patient management and outcomes; medical and pharmaceutical consultation
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
24/03/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/03/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/03/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/03/2026
IULN
ITU LETTER MAILED, NO RESPONSE REQUIRED
02/03/2026
EEXT
SOU TEAS EXTENSION RECEIVED
23/01/2026
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
24/07/2025
IUAF
USE AMENDMENT FILED
23/07/2025
EISU
TEAS STATEMENT OF USE RECEIVED
23/07/2025
EX2G
SOU EXTENSION 2 GRANTED
23/07/2025
EXT2
SOU EXTENSION 2 FILED
23/07/2025
EEXT
SOU TEAS EXTENSION RECEIVED
23/07/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/03/2025
EX1G
SOU EXTENSION 1 GRANTED
23/01/2025
EXT1
SOU EXTENSION 1 FILED
23/01/2025
EEXT
SOU TEAS EXTENSION RECEIVED
23/01/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
23/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/05/2024
PUBO
PUBLISHED FOR OPPOSITION
28/05/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/05/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
19/04/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
19/04/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
19/04/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
19/04/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
19/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/01/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/01/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
14/12/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/12/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/12/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/11/2023
GNRT
NON-FINAL ACTION E-MAILED
09/11/2023
CNRT
NON-FINAL ACTION WRITTEN
09/11/2023
DOCK
ASSIGNED TO EXAMINER
02/11/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/06/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
22/02/2023
NWAP
NEW APPLICATION ENTERED
07/02/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace FORTREA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.